Since Oneinforty was established five years ago by our visionary and impassioned founder, the late Lauren Corduck, our mission has remained the same: to raise awareness of the one-in-forty risk to those of Ashkenazi Jewish (Eastern European) descent of inheriting BRCA gene mutations, and to provide education and support to individuals and families to help them manage their cancer risk. Your participation and support for our mission has been critical to our success.
Over the past year, due to the challenges presented by the pandemic and administrative changes within the organization, it became clear to the Board of Directors that the best way to ensure the continuation of Oneinforty’ s mission and work would be to partner with an organization with a similar purpose and programs.
We have found such an organization in Sharsheret, a national nonprofit whose mission is to improve the lives of Jewish women and families living with or at increased genetic risk for breast or ovarian cancer through personalized support and save lives through educational outreach.
Under this new partnership, Oneinforty has made a significant grant to Sharsheret to develop and facilitate an educational outreach program in New England for the next five years that will focus on cancer genetics, highlighting the elevated risks for inheriting the BRCA genetic mutation and hereditary cancer among Ashkenazi Jews. Sharsheret is using the name Oneinforty in the promotion of the program and Robb Corduck, Lauren’s husband, is serving on Sharsheret’s national board to ensure the continuation of Oneinforty’s mission.
Thank you for your loyal support over the past five years, and if you wish to provide financial support to continue our mission, we invite you to do so through Sharsheret.
Please feel free to reach out with any questions about this important next step in the Oneinforty journey.
Best,
Bob Cooperstein, President
Oneinforty Board of Directors
American Jews of eastern and central European descent (Ashkenazi) have a one in forty risk of having a mutation in their BRCA1 or BRCA2 gene that puts them at much higher risk than the general population of developing ovarian cancer, breast cancer (male or female) and prostate cancer.
Both men and women are at risk of developing hereditary cancer and can pass on a BRCA 1 or 2 gene mutation. It’s important to know your family history and to speak with a genetic counselor. With knowledge of your risk, you can make informed decisions to protect you and your family’s health.
Oneinforty supports the community with an ambassador program and social media channels, offers educational symposia with expert oncologists and genetic counselors, physician education and emotional support through a cadre of mental health providers.
October 27, 2022
